Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 8 member A6, pseudogene (FAM8A6P) is a pseudogene, which means it is a DNA sequence similar to a functional gene but typically nonfunctional due to accumulated mutations preventing the production of a normal protein product[2]. There is no evidence that FAM8A6P is actively transcribed or translated into a functional protein in humans. The only related functional gene in this family is FAM8A1, which is expressed in a variety of tissues and in testis during specific spermatogenic phases[3]. Pseudogenes may sometimes have regulatory functions, for example acting as decoys for microRNAs or as sources of regulatory RNAs, but there is no published evidence supporting such roles for FAM8A6P specifically[2][5]. Pseudogenes like FAM8A6P are not considered therapeutic targets (receptor, enzyme, transporter, etc.), and they are generally not associated with direct disease mechanisms or targeted by drugs. In summary, FAM8A6P is a nonfunctional pseudogene rather than a protein-coding therapeutic target, and no evidence supports its relevance in drug targeting, disease mechanisms, or clinical biomarker roles[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 8 member A6, pseudogene (FAM8A6P).